Why and when to screen for cardiovascular disease in healthy individuals

[...]guideline-based recommendations for individuals ≥70 years are lacking despite the fact that >80% of CVD deaths occur in this age group.13 14 Nevertheless, population-based screening and intervention based on clinical risk scores does not reduce all causes or cardiovascular mortality.15 16 Al...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2021-06, Vol.107 (12), p.1010-1017
Hauptverfasser: Lindholt, Jes Sanddal, Søgaard, Rikke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]guideline-based recommendations for individuals ≥70 years are lacking despite the fact that >80% of CVD deaths occur in this age group.13 14 Nevertheless, population-based screening and intervention based on clinical risk scores does not reduce all causes or cardiovascular mortality.15 16 Although these trials were performed before or in the beginning of modern cardiovascular preventive treatment with statins, the conclusion from these trials was that screening was not needed due to the quality of the general practitioners. [...]these studies do not address the potential of modern-day screening in primary prevention. [...]the majority of these studies were in those aged
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2019-316266